H.B. Fuller Company (FUL) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Achieved 5% year-over-year growth in adjusted EBITDA and adjusted EPS for Q2 2025, with gross margin up 110 bps to 32.2% due to cost savings, acquisitions/divestitures, and pricing actions.
Net revenue for Q2 2025 decreased 2.1% year-over-year, primarily due to negative currency effects and divestitures, partially offset by pricing gains.
Operating cash flow rose $29M year-over-year to $111M; net-debt-to-EBITDA improved sequentially from 3.5x to 3.4x.
Raised full-year outlook for adjusted EBITDA and EPS due to robust execution, margin expansion, and successful portfolio transformation toward higher growth, higher margin markets.
Recognized as one of the World's Greenest Companies 2025 by Newsweek and continued focus on innovation, sustainability, and operational excellence.
Financial highlights
Q2 2025 net revenue was $898.1M, down 2.1% year-over-year; adjusting for divestitures, net revenue up 2.8%.
Adjusted EBITDA reached $166M, up 5% year-over-year; adjusted EBITDA margin expanded to 18.4%.
Adjusted EPS was $1.18, up 5% from Q2 2024; operating cash flow for Q2 was $111M, up $29M year-over-year.
Adjusted gross profit margin improved to 32.2%, up 110 bps year-over-year.
Net debt to adjusted EBITDA improved to 3.4x from 3.5x sequentially.
Outlook and guidance
FY2025 net revenue expected to decline 2%-3% year-over-year; organic revenue flat to up 2%.
Adjusted EBITDA guidance raised to $615M-$630M (4%-6% growth); adjusted EPS $4.10-$4.30 (7%-12% growth).
Full-year operating cash flow expected between $300M-$325M; Q3 EBITDA guidance $165M-$175M.
Management expects restructuring costs to total $70–$75M pre-tax, with completion by fiscal 2026.
Anticipates continued margin expansion and profit growth in the second half, despite volume constraints.
Latest events from H.B. Fuller Company
- Q2 2026 saw strong revenue, margin, and EPS growth, with a major medical acquisition announced.FUL
Q2 2026 - All proposals passed, including director elections and auditor ratification, with no shareholder questions.FUL
AGM 2026 - Adjusted EBITDA and EPS rose with margin expansion despite a 6.6% organic revenue decline.FUL
Q1 2026 - Proxy covers director elections, auditor ratification, pay, strong results, and ESG focus.FUL
Proxy Filing - Votes will be cast for director elections, auditor ratification, and executive pay approval.FUL
Proxy Filing - Margin and EPS growth achieved through cost actions and acquisitions despite revenue headwinds.FUL
Q4 2025 - Q3 2024 saw 6% EBITDA and 7% EPS growth, led by strong Construction Adhesives results.FUL
Q3 2024 - Adjusted EPS up 20% and EBITDA up 10% year-over-year, with 2024 guidance raised.FUL
Q2 2024 - FY24 revenue up 1.6%, margin at 16.6%; 2025 outlook cautious with cost and footprint actions.FUL
Q4 2024